{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:09:57Z","timestamp":1791475797818,"version":"4.3.4"},"reference-count":56,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T00:00:00Z","timestamp":1672272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Council of Scientific and Industrial Research, India"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>The Corona Virus Infectious Disease-2019 (COVID-19) outbreak originated at Wuhan, China, in December 2019. It has already spread rapidly and caused more than 6.5 million deaths worldwide. Its causal agent is a beta-coronavirus named SARS-CoV-2. Many efforts have already been made to develop new vaccines and drugs against these viruses, but over time, it has changed its molecular nature and evolved into more lethal variants, such as Delta and Omicron. These will lead us to target its more-conserved proteins. The sequences\u2019 BLAST and crystal structure of the main protease Mpro suggest a high sequence and structural conservation. Mpro is responsible for the proteolytic maturation of the polyprotein essential for the viral replication and transcription, which makes it an important drug target. Discovery of new drug molecules may take years before getting to the clinics. So, considering urgency, we performed molecular docking studies using FDA-approved drugs to identify molecules that could potentially bind to the substrate-binding site and inhibit SARS-CoV-2\u2019s main protease (Mpro). We used the Glide module in the Schr\u00f6dinger software suite to perform molecular docking studies, followed by MM-GBSA-based energy calculations to score the hit molecules. Molecular docking and manual analysis suggest that several drugs may bind and potentially inhibit Mpro. We also performed molecular simulations studies for selected compounds to evaluate protein\u2013drug interactions. Considering bioavailability, lesser toxicity, and route of administration, some of the top-ranked drugs, including lumefantrine (antimalarial), dipyridamole (coronary vasodilator), dihydroergotamine (used for treating migraine), hexoprenaline (anti asthmatic), riboflavin (vitamin B2), and pantethine (vitamin B5) may be taken forward for further in vitro and in vivo experiments to investigate their therapeutic potential.<\/jats:p>","DOI":"10.3390\/biomedicines11010085","type":"journal-article","created":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T03:31:17Z","timestamp":1672371077000},"page":"85","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Potential Inhibitors of SARS-CoV-2 Main Protease (Mpro) Identified from the Library of FDA-Approved Drugs Using Molecular Docking Studies"],"prefix":"10.3390","volume":"11","author":[{"given":"Dipesh Kumar","family":"Verma","sequence":"first","affiliation":[{"name":"Structural Biology Laboratory, CSIR-Institute of Microbial Technology, Chandigarh 160036, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1347-550X","authenticated-orcid":false,"given":"Srajan","family":"Kapoor","sequence":"additional","affiliation":[{"name":"Structural Biology Laboratory, CSIR-Institute of Microbial Technology, Chandigarh 160036, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satyajeet","family":"Das","sequence":"additional","affiliation":[{"name":"Structural Biology Laboratory, CSIR-Institute of Microbial Technology, Chandigarh 160036, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4500-2133","authenticated-orcid":false,"given":"Krishan Gopal","family":"Thakur","sequence":"additional","affiliation":[{"name":"Structural Biology Laboratory, CSIR-Institute of Microbial Technology, Chandigarh 160036, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Adem, S., Eyupoglu, V., Sarfraz, I., Rasul, A., and Ali, M. (2020). Identification of Potent COVID-19 Main Protease (Mpro) Inhibitors from Natural Polyphenols: An In Silico Strategy Unveils a Hope against CORONA. Mol. Biol.","DOI":"10.20944\/preprints202003.0333.v1"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"101615","DOI":"10.1016\/j.tmaid.2020.101615","article-title":"Remdesivir as a possible therapeutic option for the COVID-19","volume":"34","author":"Memish","year":"2020","journal-title":"Travel Med. Infect. Dis."},{"key":"ref_3","first-page":"741018","article-title":"Side effects of radiographic contrast media: Pathogenesis, risk factors, and prevention","volume":"2014","author":"Andreucci","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"682","DOI":"10.2174\/1570163816666190823135948","article-title":"Kaempferol as a Potential PAK4 Inhibitor in Triple Negative Breast Cancer: Extra Precision Glide Docking and Free Energy Calculation","volume":"17","author":"Arowosegbe","year":"2020","journal-title":"Curr. Drug Discov. Technol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"W529","DOI":"10.1093\/nar\/gkq399","article-title":"ConSurf 2010: Calculating evolutionary conservation in sequence and structure of proteins and nucleic acids","volume":"38","author":"Ashkenazy","year":"2010","journal-title":"Nucleic. Acids Res."},{"key":"ref_6","first-page":"111544","article-title":"Identification of FDA approved drugs targeting COVID-19 virus by structure-based drug repositioning","volume":"138","author":"Ayman","year":"2020","journal-title":"ChemRxiv"},{"key":"ref_7","first-page":"134","article-title":"A possible mechanism for the neural adverse reactions caused by metrizamide","volume":"128","author":"Azuma","year":"1989","journal-title":"Geb Rontgenstrahlen Nukl. Erganz."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF00339196","article-title":"Myelography with iopamidol, a nonionic water- soluble contrast medium: Incidence of complications","volume":"24","author":"Bassi","year":"1982","journal-title":"Neuroradiology"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Bowers, K., Chow, E., Huageng, X., Dror, R.O., Eastwood, M.P., Gregersen, B., Klepeis, J., Kolossv\u00e1ry, I., Moraes, M.A., and Sacerdoti, F.D. (2006, January 11\u201317). Scalable Algorithms for Molecular Dynamics Simulations on Commodity Clusters. Proceedings of the 2006 ACM\/IEEE Conference on Supercomputing, Tampa, FL, USA.","DOI":"10.1145\/1188455.1188544"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1002\/j.1460-2075.1987.tb02713.x","article-title":"An efficient ribosomal frame-shifting signal in the polymerase-encoding region of the coronavirus IBV","volume":"6","author":"Brierley","year":"1987","journal-title":"EMBO J."},{"key":"ref_11","first-page":"123","article-title":"Palbociclib: An evidence-based review of its potential in the treatment of breast cancer","volume":"6","author":"Cadoo","year":"2014","journal-title":"Breast Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1021\/ci100026x","article-title":"Drug-like Bioactive Structures and Conformational Coverage with the LigPrep\/ConfGen Suite: Comparison to Programs MOE and Catalyst","volume":"50","author":"Chen","year":"2010","journal-title":"J. Chem. Inf. Model."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","article-title":"European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke","volume":"143","author":"Diener","year":"1996","journal-title":"J. Neurol. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1148\/radiology.147.1.6828715","article-title":"Metrizamide\u2014A potential in vivo inhibitor of glucose metabolism","volume":"147","author":"Ekholm","year":"1983","journal-title":"Radiology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J. Med. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Gao, Y., Yan, L., Huang, Y., Liu, F., Zhao, Y., Cao, L., Wang, T., Sun, Q., Ming, Z., and Zhang, L. (2020). Structure of RNA-dependent RNA polymerase from 2019-nCoV, a major antiviral drug target. bioRxiv.","DOI":"10.1101\/2020.03.16.993386"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Ge, Y., Tian, T., Huang, S., Wan, F., Li, J., Li, S., Yang, H., Hong, L., Wu, N., and Yuan, E. (2020). A data- driven drug repositioning framework discovered a potential therapeutic agent targeting COVID-19. bioRxiv.","DOI":"10.1101\/2020.03.11.986836"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_19","first-page":"11","article-title":"The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak-an update on the status","volume":"7","author":"Guo","year":"2020","journal-title":"Mil. Med. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1423-0127-16-31","article-title":"Studies on the binding affinity of anticancer drug mitoxantrone to chromatin, DNA and histone proteins","volume":"16","author":"Hajihassan","year":"2009","journal-title":"J. Biomed. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1747-0285.2007.00483.x","article-title":"New Method for Fast and Accurate Binding-site Identification and Analysis","volume":"69","author":"Halgren","year":"2007","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1021\/ci800324m","article-title":"Identifying and Characterizing Binding Sites and Assessing Druggability","volume":"49","author":"Halgren","year":"2009","journal-title":"J. Chem. Inf. Model."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: A New Approach for Rapid, Accurate Docking and Scoring. 2. Enrichment Factors in Database Screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J. Med. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1021\/acs.jctc.5b00864","article-title":"OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins","volume":"12","author":"Harder","year":"2016","journal-title":"J. Chem. Theory Comput."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"ref_26","unstructured":"Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., Zhang, B., Li, X., Zhang, L., and Peng, C. (2020). Structure of Mpro from COVID-19 virus and discovery of its inhibitors. bioRxiv."},{"key":"ref_27","first-page":"2020030226","article-title":"Potential Inhibitor of COVID- 19 Main Protease (Mpro) From Several Medicinal Plant Compounds by Molecular Docking Study","volume":"2020","author":"Khaerunnisa","year":"2020","journal-title":"Preprints"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Kloprogge, F., Workman, L., Borrmann, S., Tekete, M., Lefevre, G., Hamed, K., Piola, P., Ursing, J., Kofoed, P.E., and Martensson, A. (2018). Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysis. PLoS Med., 15.","DOI":"10.1371\/journal.pmed.1002579"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fvets.2019.00034","article-title":"PEDV and PDCoV Pathogenesis: The Interplay Between Host Innate Immune Responses and Porcine Enteric Coronaviruses","volume":"6","author":"Koonpaew","year":"2019","journal-title":"Front. Vet. Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","article-title":"Structure, Function, and Evolution of Coronavirus Spike Proteins","volume":"3","author":"Li","year":"2016","journal-title":"Annu. Rev. Virol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1071\/MA20013","article-title":"COVID-19: A novel zoonotic disease caused by a coronavirus from China: What we know and what we don\u2019t","volume":"41","author":"Mackenzie","year":"2020","journal-title":"Microbiol. Aust."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18388\/abp.1998_4280","article-title":"The geometry of intercalation complex of antitumor mitoxantrone and ametantrone with DNA: Molecular dynamics simulations","volume":"45","author":"Mazerski","year":"1998","journal-title":"Acta Biochim. Pol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0002-9343(83)91265-2","article-title":"Animal toxicity and pharmacokinetics of hydroxychloroquine sulfate","volume":"75","author":"McChesney","year":"1983","journal-title":"Am. J. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.virusres.2014.11.021","article-title":"Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis","volume":"202","author":"Millet","year":"2015","journal-title":"Virus Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1259\/0007-1285-61-732-1175","article-title":"A slice width and focal spot alignment camera for computed tomographic scanners","volume":"61","author":"Mott","year":"1988","journal-title":"Br. J. Radiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/iub.2359","article-title":"T Vitamin B12 May Inhibit RNA-Dependent-RNA Polymerase Activity of nsp12 from the SARS-CoV-2 Virus","volume":"72","author":"Narayanan","year":"2020","journal-title":"IUBMB Life"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/bioinformatics\/btm076","article-title":"COBALT: Constraint-based alignment tool for multiple protein sequences","volume":"23","author":"Papadopoulos","year":"2007","journal-title":"Bioinformatics"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1758835919833519","DOI":"10.1177\/1758835919833519","article-title":"HER2-positive breast cancer: New therapeutic frontiers and overcoming resistance","volume":"11","author":"Pernas","year":"2019","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-197714010-00001","article-title":"Hexoprenaline: A review of its pharmacological properties and therapeutic efficacy with particular reference to asthma","volume":"14","author":"Pinder","year":"1977","journal-title":"Drugs"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"56","DOI":"10.4103\/ijp.IJP_115_20","article-title":"Drug targets for corona virus: A systematic review","volume":"52","author":"Prajapat","year":"2020","journal-title":"Indian J. Pharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"W320","DOI":"10.1093\/nar\/gku316","article-title":"Deciphering key features in protein structures with the new ENDscript server","volume":"42","author":"Robert","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/01.GME.0000063609.62485.27","article-title":"Effects of ospemifene, a novel SERM, on hormones, genital tract, climacteric symptoms, and quality of life in postmenopausal women: A double-blind, randomized trial","volume":"10","author":"Rutanen","year":"2003","journal-title":"Menopause"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12985-019-1182-0","article-title":"Coronavirus envelope protein: Current knowledge","volume":"16","author":"Schoeman","year":"2019","journal-title":"Virol. J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1526-4610.2007.01006.x","article-title":"Safety and pharmacokinetics of dihydroergotamine mesylate administered via a Novel (Tempo) inhaler","volume":"48","author":"Shrewsbury","year":"2008","journal-title":"Headache"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"11876","DOI":"10.1073\/pnas.0505577102","article-title":"Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry","volume":"102","author":"Simmons","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/j.1875-9114.1986.tb03451.x","article-title":"Acebutolol: A review of its pharmacology, pharmacokinetics, clinical uses, and adverse effects","volume":"6","author":"Singh","year":"1986","journal-title":"Pharmacotherapy"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"11157","DOI":"10.1073\/pnas.1708727114","article-title":"Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion","volume":"114","author":"Walls","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"10630","DOI":"10.1093\/nar\/gkt828","article-title":"On the structural basis and design guidelines for type II topoisomerase-targeting anticancer drugs","volume":"41","author":"Wu","year":"2013","journal-title":"Nucleic. Acids Res."},{"key":"ref_49","first-page":"1939","article-title":"Safety and efficacy of ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy due to menopause","volume":"9","author":"Wurz","year":"2014","journal-title":"Clin. Interv. Aging"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1128\/JVI.02114-07","article-title":"Structures of Two Coronavirus Main Proteases: Implications for Substrate Binding and Antiviral Drug Design","volume":"82","author":"Xue","year":"2008","journal-title":"J. Virol."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Yang, H., Xie, W., Xue, X., Yang, K., Ma, J., Liang, W., Zhao, Q., Zhou, Z., Pei, D., and Ziebuhr, J. (2005). Design of wide-spectrum inhibitors targeting coronavirus main proteases. PLoS Biol., 3.","DOI":"10.1371\/journal.pbio.0030428"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"146134","DOI":"10.1016\/j.gene.2021.146134","article-title":"From delta to Omicron: S1-RBD\/S2 mutation\/deletion equilibrium in SARS-CoV-2 defined variants","volume":"814","author":"Papanikolaou","year":"2022","journal-title":"Gene"},{"key":"ref_53","first-page":"8012","article-title":"Omicron SARS-CoV-2 new variant: Global prevalence and biological and clinical characteristics","volume":"25","author":"Meo","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"101549","DOI":"10.1016\/j.genrep.2022.101549","article-title":"Omicron: A highly transmissible SARS-CoV-2 variant","volume":"27","author":"Rahimi","year":"2022","journal-title":"Gene Rep."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12998\/wjcc.v10.i1.1","article-title":"Omicron variant (B.1.1.529) of SARS-CoV-2: Mutation, infectivity, transmission, and vaccine resistance","volume":"10","author":"Ren","year":"2022","journal-title":"World J. Clin. Cases"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41586-021-03944-y","article-title":"SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion","volume":"599","author":"Mlcochova","year":"2021","journal-title":"Nature"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/11\/1\/85\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:55:12Z","timestamp":1760147712000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/11\/1\/85"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,29]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["biomedicines11010085"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines11010085","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,29]]}}}